{
  "ticker": "PRTA",
  "company_name": "Prothena Corporation plc",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06699680",
      "title": "Phase 1 Study of PRX019 in Healthy Adult Volunteers",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Healthy Participants Study",
      "start_date": "2024-11-08",
      "completion_date": "2026-01-23",
      "enrollment": 0,
      "sponsor": "Prothena Biosciences Ltd."
    },
    {
      "nct_id": "NCT02312206",
      "title": "The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Primary Systemic (AL) Amyloidosis",
      "start_date": "2015-02",
      "completion_date": "2018-05",
      "enrollment": 0,
      "sponsor": "Prothena Biosciences Ltd."
    },
    {
      "nct_id": "NCT02632786",
      "title": "The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "AL Amyloidosis",
      "start_date": "2016-03",
      "completion_date": "2018-03",
      "enrollment": 0,
      "sponsor": "Prothena Biosciences Ltd."
    },
    {
      "nct_id": "NCT01707264",
      "title": "Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Primary Amyloidosis",
      "start_date": "2013-04",
      "completion_date": "2016-08-09",
      "enrollment": 0,
      "sponsor": "Prothena Biosciences Ltd."
    },
    {
      "nct_id": "NCT02574676",
      "title": "Quality of Life (QOL) Registry for Patients With AL Amyloidosis",
      "status": "COMPLETED",
      "phase": "",
      "condition": "AL Amyloidosis, Amyloidosis",
      "start_date": "2015-10",
      "completion_date": "2018-07",
      "enrollment": 0,
      "sponsor": "Prothena Biosciences Ltd."
    },
    {
      "nct_id": "NCT04973137",
      "title": "A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Light Chain (AL) Amyloidosis",
      "start_date": "2021-08-30",
      "completion_date": "2025-06-20",
      "enrollment": 0,
      "sponsor": "Prothena Biosciences Ltd."
    },
    {
      "nct_id": "NCT03154047",
      "title": "Study in Subjects With Light Chain (AL) Amyloidosis",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "AL Amyloidosis",
      "start_date": "2017-06-14",
      "completion_date": "2018-05-30",
      "enrollment": 0,
      "sponsor": "Prothena Biosciences Ltd."
    },
    {
      "nct_id": "NCT02613182",
      "title": "Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "AL Amyloidosis",
      "start_date": "2016-02",
      "completion_date": "2018-05",
      "enrollment": 0,
      "sponsor": "Prothena Biosciences Ltd."
    },
    {
      "nct_id": "NCT07174310",
      "title": "A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Parkinson's Disease",
      "start_date": "2025-11-24",
      "completion_date": "2031-06-30",
      "enrollment": 0,
      "sponsor": "Hoffmann-La Roche"
    },
    {
      "nct_id": "NCT02630901",
      "title": "Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Psoriasis",
      "start_date": "2016-03-17",
      "completion_date": "2018-02-28",
      "enrollment": 0,
      "sponsor": "Prothena Biosciences Limited"
    }
  ],
  "summary": {
    "total_trials": 17,
    "by_phase": {
      "PHASE1": 6,
      "PHASE3": 3,
      "PHASE2": 5,
      "PHASE1, PHASE2": 1,
      "": 2
    },
    "by_status": {
      "RECRUITING": 2,
      "TERMINATED": 5,
      "COMPLETED": 8,
      "ACTIVE_NOT_RECRUITING": 2
    },
    "active_trials": 4,
    "completed_trials": 8,
    "conditions": [
      "AL Amyloidosis",
      "AL Amyloidosis, Amyloidosis",
      "Amyloidogenic Transthyretin (ATTR) Amyloidosis",
      "Healthy Participants Study",
      "Light Chain (AL) Amyloidosis",
      "Parkinson's Disease",
      "Parkinsons Disease",
      "Primary Amyloidosis",
      "Primary Systemic (AL) Amyloidosis",
      "Psoriasis"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:21:02.774110",
    "search_query": "Prothena Corporation plc",
    "url": "https://clinicaltrials.gov/search?term=Prothena+Corporation+plc"
  }
}